Solutions 4 Wealth, LTD Outlook Therapeutics, Inc. Transaction History

Solutions 4 Wealth, LTD

  • $44.1 Billion
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024
BUY
$0.22 - $0.66 $7,215 - $21,646
32,798 New
32,798 $12.9 Million

Others Institutions Holding OTLK

# of Institutions
3
Shares Held
31.5K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.18B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Solutions 4 Wealth, LTD Portfolio

Follow Solutions 4 Wealth, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Solutions 4 Wealth, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Solutions 4 Wealth, LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email